EHA Library - The official digital education library of European Hematology Association (EHA)

BACTEREMIA IN PEDIATRIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Author(s): ,
Bechiro Achouro
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Marzouk Manel
Affiliations:
Microbiology,Farhat Hached Hospital,Sousse,Tunisia
,
Amal Chalbaoui
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Akoudad Asma
Affiliations:
Community Medecine,Farhat Hached Hospital,Sousse,Tunisia
,
Elhadded Nihel
Affiliations:
Community Medecine,Farhat Hached Hospital,Sousse,Tunisia
,
Bouslema Emna
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Regaieg Haifa
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Bensayed Nesrine
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Kmira Zahra
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Zaier Monia
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Benyoussef Yosra
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Boukadida Jalel
Affiliations:
Microbiology,Farhat Hached Hospital,Sousse,Tunisia
Khelif Abderrahim
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
EHA Library. ACHOUR B. 06/09/21; 324263; PB1586
Prof. Dr. BECHIR ACHOUR
Prof. Dr. BECHIR ACHOUR
Contributions
Abstract

Abstract: PB1586

Type: Publication Only

Session title: Infections in hematology (incl. supportive care/therapy)

Background
Bacteraemia adversely affect the outcome of pediatric patients with hematologic malignancies.

Aims

This study aimed to describe the epidemiology, outcome, and factor influencing mortality of bacteremia in children with hematologic malignancies.

Methods

This is a descriptive retrospective study. Data belonging to bacteraemia in pediatric (<16 years) patients with hematologic malignancies admitted in our department of hematology during the period spanning from January 2010 and November 2019 were analyzed. Risk factors with a P-value less than 0.20 were initially included in the binary logistic regression model to determine the independent risk factors for mortality Bloodstream infection in adult hematologic malignancies. Factors described in previous literature were also included in the model. Then the model was reduced by means of manual backward elimination. P values ≤ 0.05 were considered statistically significant.

Results

One hundred thirty nine bacteremia episodes among 110 patients were identified. Underlying diseases were acute lymphoblastic leukemia (ALL) 106(76.3%) which far exceeds acute myeloid leukemia (AML) 29 (20.9%). The bacteraemia occurred in 68 patients with uncontrolled/ relapse or refractory disease. The majority of BSI episodes occurred in the presence of severe neutropenia (62.6%). Ninety-four (67.6%) of the culture isolates were Gram-negative bacteria and 45 (32.4%) were Gram-positive bacteria. Klebsiella species and Escherichia coli were the most common Gram-negative isolates. Staphylococcus aureus and staphylococcus epidermidis were the most common Gram-positive isolates. A multidrug-resistant bacteria was present in 31 (22.3%) cases. In 96 (69.1%) episodes, patients received an appropriate antibiotherapy. Complications occurred in 24 (17.3%) episodes of bacteremia. seven children died during bacteremia, giving a case-fatality rate of 5%. The independent risk Factor influencing mortality were : qSOFA>2 (P: 0.002).

Conclusion

Bacteremia in these patients was caused mainly by Gram-negative microorganisms and was associated with a low case-fatality rate. Factor influencing mortality was qSOFA>2.

Keyword(s): Hematological malignancy, Infection, Pediatric

Abstract: PB1586

Type: Publication Only

Session title: Infections in hematology (incl. supportive care/therapy)

Background
Bacteraemia adversely affect the outcome of pediatric patients with hematologic malignancies.

Aims

This study aimed to describe the epidemiology, outcome, and factor influencing mortality of bacteremia in children with hematologic malignancies.

Methods

This is a descriptive retrospective study. Data belonging to bacteraemia in pediatric (<16 years) patients with hematologic malignancies admitted in our department of hematology during the period spanning from January 2010 and November 2019 were analyzed. Risk factors with a P-value less than 0.20 were initially included in the binary logistic regression model to determine the independent risk factors for mortality Bloodstream infection in adult hematologic malignancies. Factors described in previous literature were also included in the model. Then the model was reduced by means of manual backward elimination. P values ≤ 0.05 were considered statistically significant.

Results

One hundred thirty nine bacteremia episodes among 110 patients were identified. Underlying diseases were acute lymphoblastic leukemia (ALL) 106(76.3%) which far exceeds acute myeloid leukemia (AML) 29 (20.9%). The bacteraemia occurred in 68 patients with uncontrolled/ relapse or refractory disease. The majority of BSI episodes occurred in the presence of severe neutropenia (62.6%). Ninety-four (67.6%) of the culture isolates were Gram-negative bacteria and 45 (32.4%) were Gram-positive bacteria. Klebsiella species and Escherichia coli were the most common Gram-negative isolates. Staphylococcus aureus and staphylococcus epidermidis were the most common Gram-positive isolates. A multidrug-resistant bacteria was present in 31 (22.3%) cases. In 96 (69.1%) episodes, patients received an appropriate antibiotherapy. Complications occurred in 24 (17.3%) episodes of bacteremia. seven children died during bacteremia, giving a case-fatality rate of 5%. The independent risk Factor influencing mortality were : qSOFA>2 (P: 0.002).

Conclusion

Bacteremia in these patients was caused mainly by Gram-negative microorganisms and was associated with a low case-fatality rate. Factor influencing mortality was qSOFA>2.

Keyword(s): Hematological malignancy, Infection, Pediatric

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies